Inventor

Francis S. Collins

Inventor
Rockville, MD, US

Overview

30→
Patents
1993–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms19%
A61KPreparations for medical, dental or toiletry purposes16%
C12NMicroorganisms or enzymes9%
A01KAnimal husbandry8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
B82YSpecific uses or applications of nanostructures6%
Y10TTechnical subjects covered by former us classification4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
10,822,608Oligonucleotide analogues targeting human LMNA202010,398,721Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA20199,833,468Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA20179,326,992'Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA'20169,115,400'LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis'20158,828,356'Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis'20148,691,501'Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis'20148,535,884'LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis'20138,257,915'Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis'20128,034,557'LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis'20117,838,531'Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis'20107,358,347'MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof'20087,297,492'LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis'20076,984,487'Cystic fibrosis gene'20066,902,907'Cystic fibrosis gene'20056,730,777'Cystic fibrosis gene'20046,627,745'Pyrin gene and mutants thereof, which cause familial Mediterranean fever'20036,342,355'Probe-based analysis of heterozygous mutations using two-color labelling'20026,238,861'Neurofibromatosis gene'20016,211,336'Ataxia-telangiectasia gene'20016,201,107'Cystic fibrosis gene'20016,013,449'Probe-based analysis of heterozygous mutations using two-color labelling'20005,869,611'Markers for detection of chromosome 16 rearrangements'19995,859,195'Neurofibromatosis gene'19995,837,457'Markers for detection of chromosome 16 rearrangements'19985,777,093'cDNAs associated with ataxia-telangiectasia'19985,776,677'Methods of detecting cystic fibrosis gene by nucleic acid hybridization'19985,728,807'Mutated proteins associated with ataxia-telangiectasia'19985,434,086'Method of testing potential cystic fibrosis treating compounds using cells in culture'19955,240,846'Gene therapy vector for cystic fibrosis'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2014Patents assigned to UNIV MICHIGAN (15)· patent assignee history
1993–2006Based in Ann Arbor, MI, US· patent location history
1998–2015Based in Rockville, MD, US· patent location history
1998–2020Based in Bethesda, MD, US· patent location history
2000–2020Patents assigned to US HEALTH (17)· patent assignee history
2007–2019Patents assigned to PROGERIA RES FOUNDATION INC (9)· patent assignee history
2007–2015Patents assigned to RES FOUND MENTAL HYGIENE (4)· patent assignee history
2016–2020Patents assigned to SAREPTA THERAPEUTICS INC (4)· patent assignee history
2016–2019Based in Chevy Chase, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
US HEALTH172000–2020
UNIV MICHIGAN151993–2014
PROGERIA RES FOUNDATION INC92007–2019
RES FOUND MENTAL HYGIENE42007–2015
SAREPTA THERAPEUTICS INC42016–2020
Locations
LocationPatentsSpan
Rockville, Maryland, US151998–2015
Ann Arbor, MI, US91993–2006
Bethesda, Maryland, US31998–2020
Chevy Chase, Maryland, US32016–2019